Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Whole Blood vs. Blood Components Therapy in the Hemostatic Resuscitation of Severe Trauma Patients: An Open-label, Randomized, Controlled Clinical Trial

NCT05634109 is registered in ClinicalTrials.gov with Fundacion Clinica Valle del Lili as lead sponsor.

NCT NCT05634109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05634109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Whole Blood vs. Blood Components Therapy in the Hemostatic Resuscitation of Severe Trauma Patients: An Open-label, Randomized, Controlled Clinical Trial
Lead sponsor
Fundacion Clinica Valle del Lili
Phase
Phase 3
Overall status
Recruiting
Start date
January 14, 2023
Completion date
March 31, 2026
Enrollment
220 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

trauma, trauma injury, trauma, multiple